- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06562556
Impact of Breather Device on Ventilatory Effort in Patient With MTMD
Impact of Breather Device on Ventilatory Effort in Patient With Myogenic Temporomandibular Joint Disorders
PURPOSE:
The purpose of the study is to investigate the effect of the breather device on ventilatory effort and in patients with myogenic temporomandibular joint disorders To investigate the effect of the breather device on craniocervical angle and oral Health quality in patients with myogenic temporomandibular joint disorders
BACKGROUND:
TMDs affect between 5% and 12% of the population which is presented by symptoms such as pain in the masticatory muscles with a decrease in the mandible's movement. Other symptoms include ear pain, headache, joint sounds with mandible movement, and/or functional limitations in the jaw like swallowing difficulties commonly found. (Hatice ., et al 2023) Increased prevalence of TMDs has been linked to physical, psychological, and hormonal changes throughout pubertal development. The age predisposes to the development of masticatory system problems in students since symptoms peak between the ages of 20 and 40 years. Women of breeding age are the majority of TMD sufferers. The prevalence of TMD increases globally throughout adolescence and may vary from 7% to 30% of the population (Loster ., et al2017). Alterations of body posture, upper thoracic breathing pattern, and mouth breathing constitute causal factors for the overuse of the accessory inspiratory musculature, which generates hyperactivity and consequently, alteration of head position, and mandibular traction. (Kim., et al 2017)
HYPOTHESES:
There will be no significant effect of the breather device on ventilatory effort in patients with myogenic temporomandibular joint disorders.
There will be no significant effect of the breather device on a craniocervical angle and oral Health quality in patients with myogenic temporomandibular joint disorders RESEARCH QUESTION: Does the breather device can improve ventilatory effort in patients with myogenic temporomandibular joint disorders?.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Randomized controlled trial which will be conducted on sixty female patients with chronic pain myogenous TMD for more than three months will be included in our study., their ages will range from 20 to 30 years. They will be selected from students of Misr University for Science and Technology to be enrolled in this study. They will participate in this study for 4 weeks The patients will participate and randomly be assigned into two equal groups. Group A: (Experimental group) Thirty patients, will receive a combined treatment program containing respiratory muscle training by the breather device with a conventional exercise program for MTMD for four consecutive weeks (3 sessions/ week).
Group B: (Control group) Thirty patients, who will receive a conventional exercise program for MTMD for four consecutive weeks (3 sessions/ week)
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: weaam Hasaneen, assistant lecturer
- Phone Number: 010111421509
- Email: weaam.hosain@must.edu.eg
Study Contact Backup
- Name: Hany Ezzat, Assistant professor
- Phone Number: 01001746517
- Email: Hany_obaya@yahoo.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Inclusion criteria:
- Sixty female patients who fulfilled the RDC/TMD criteria of myofascial pain and the presence of parafunctional habits, such as bruxism, teeth grinding, mouth breathing, and lip biting.
- The Patient's ages will range from 20 to 40 years.
4- Patients with a waist-height ratio measuring less than 0.5. 5- Patients with a craniocervical angle measuring from 30 to 50° (Bo-Been et al., 2016).
6- the patients have points from 20-65 on the Fonseca Anamnestic Index (FAI) 7- the patients have the willingness to participate in this study. 8- All patients will sign a consent form before starting the study.
Exclusion Criteria:
Patients will meet one of the following criteria will be excluded from the study:
- patients undergo surgery or trauma in the orofacial region; systemic or degenerative odontologic disease.
- The patient has Surgery or trauma in the spine and upper limb.
- Patients suffering from rheumatic diseases and other severe comorbidities.
- Patients suffering from any respiratory diseases (restrictive, obstructive, suppurative diseases).
- Patients suffering from neurological disorders affecting respiratory muscles or any muscular dystrophies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participant Group/Arm
rThirty patients, will receive a combined treatment program containing respiratory muscle training by the breather device with a conventional exercise program for MTMD for four consecutive weeks (3 sessions/ week)
|
investigate the effect of the breather device on ventilatory effort and in patients with myogenic temporomandibular joint disorders
-Therapeutic Ultrasound (US): Ultrasound therapy will be applied at the site of pain over the TMJ area with Frequency: 1 MHz, Mode: continuous, Duration: 6 min. each session 2-Myofascial release for masticatory muscles 3-The self-exercise Self exercise: include simplified myo-functional therapy. 10 repetitions, three: five times per day 4-Techniques to correct deglutition: swallowing a small amount of water and speaking while holding a semi-hard small object between the dental arches 5-Relaxation exercise of Masticator Muscle:10 repetitions, three. 6-Strain-counterstain (SCS): applied on the tender or trigger points of neck muscles on improving pain and pressure pain sensitivity in neck muscles |
|
Other: Control group/Arm
Thirty patients, who will receive a conventional exercise program for MTMD for four consecutive weeks (3 sessions/ week).
|
-Therapeutic Ultrasound (US): Ultrasound therapy will be applied at the site of pain over the TMJ area with Frequency: 1 MHz, Mode: continuous, Duration: 6 min. each session 2-Myofascial release for masticatory muscles 3-The self-exercise Self exercise: include simplified myo-functional therapy. 10 repetitions, three: five times per day 4-Techniques to correct deglutition: swallowing a small amount of water and speaking while holding a semi-hard small object between the dental arches 5-Relaxation exercise of Masticator Muscle:10 repetitions, three. 6-Strain-counterstain (SCS): applied on the tender or trigger points of neck muscles on improving pain and pressure pain sensitivity in neck muscles |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
spirometer
Time Frame: 4 weeks
|
measure ventilatory function test in percentage
|
4 weeks
|
|
Surface electromyography (sEMG):
Time Frame: 4 weeks
|
To evaluate nerve-muscle activity during static conditions and active movements of the scalene muscle and sternocleidomastoid muscle
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fonseca Anamnestic Index (FAI)
Time Frame: 4 weeks
|
to diagnose TMD and evaluate the severity of the disorder.
FAI is a functional assessment scale, which contains 10 objective questions which there are three possible answers: no 0 points, sometimes 5 points, and yes 10 points.
The total score gives the FAI classification as follows: 70-100 points, severe TMD.
45-65 points, moderate TMD.
20-40 points, mild TMD.
0-15 points, TMD-free.
TMD is diagnosed on FAI scores of ≥20
|
4 weeks
|
|
Numeric Pain Rating Scale (NPRS)
Time Frame: 4 weeks
|
To assess neck Pain intensity on a scale from 0 to 10 using whole Arabic numbers.
|
4 weeks
|
|
craniocervical angle measuring
Time Frame: 4 weeks
|
Kinovea software
|
4 weeks
|
|
The Oral Health Impact Profile Questionnaire OHIP-14
Time Frame: 4 weeks
|
to determine oral health quality.
comprises 14 items that explore seven dimensions of impact: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap.
The responses were classified using the Likert scale with five options ranging from "never" (0) to "very often" (4)
|
4 weeks
|
|
Tape Measurement tool and height scale
Time Frame: preassessment
|
To measure the waist/ height ratio
|
preassessment
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- breather device for MTMD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on TMD
-
Alexandria UniversityRecruiting
-
Cairo UniversityNot yet recruiting
-
University of L'AquilaCompleted
-
Erchonia CorporationRecruitingTMD | TMJ Pain | TMJUnited States
-
Tayfun ISIKThe Scientific and Technological Research Council of TurkeyRecruitingTMD | TMD/Orofacial PainTurkey (Türkiye)
-
Mansoura UniversityActive, not recruitingTMD | TMD/Orofacial Pain | Temporomandibular Disorder (TMD)Egypt
-
University of Maryland, BaltimoreNeuroscience Research AustraliaCompleted
-
Cairo UniversityNot yet recruitingTMD | TMJ Disc Displacement With Reduction | PRP Injection
Clinical Trials on the breather device
-
Riphah International UniversityNot yet recruiting
-
Cairo UniversityCompletedPneumonia Hospital AcquiredEgypt
-
Riphah International UniversityNot yet recruiting
-
Cairo UniversityRecruiting
-
Donna SchumanUniversity of Kentucky; Happify Inc.Withdrawn
-
Horus UniversityNot yet recruitingCOVID-19 | COPDEgypt
-
Cairo UniversityRecruitingRespiratory Muscle Training | Post-Cardiac Surgery Patients | Respiratory Muscle Weakness | Post Coronary Artery Bypass Grafting | Upper Cross SyndromeEgypt
-
Adly A AdamCompleted
-
Cairo UniversityCompleted
-
Luminate Medical, Inc.RecruitingChemotherapy Induced Peripheral Neuropathy (CIPN)United States, Ireland